Wearable technology in inflammatory bowel disease: current state and future direction
Sidharth Harindranath1,2, Devendra Desai2
1Department of Gastroenterology, Seth GS medical college and KEM hospital, Mumbai, India.
Expert Review of Medical Devices
|January 11, 2025
Summary
Wearable technology, including smartwatches and sensors, is increasingly used for monitoring inflammatory bowel disease (IBD) and predicting flares. Future applications promise early detection and personalized treatment for IBD patients.
Area of Science:
- Biomedical Engineering
- Digital Health
- Gastroenterology
Background:
- Wearable devices collect physiological data through sensors.
- Smartwatches and patches are examples of wearable technology.
- Inflammatory Bowel Disease (IBD) management can benefit from continuous health monitoring.
Purpose of the Study:
- To review the current applications of wearable technology in IBD patient care.
- To explore the future potential of wearables in IBD management.
- To discuss limitations and propose future directions for digital health in IBD.
Main Methods:
- Comprehensive literature search of PubMed, MEDLINE, Embase, and Scopus.
- Analysis of studies on wearable technology in healthcare and IBD.
- Review of current and emerging applications of wearable sensors.
Main Results:
- Wearables are currently used for IBD monitoring and flare prediction.
- Future applications include biosensors for early detection and ingestible devices for data collection.
- Integration with machine learning is a key future advancement.
Conclusions:
- Wearable technology offers significant potential to improve IBD management.
- Advancements aim for early diagnosis, personalized treatment, and better patient outcomes.
- Addressing limitations in digital health data is crucial for effective clinical integration.
Keywords:
Inflammatory bowel diseasesdigital healthearly diagnosisprecision medicinewearable electronic deviceMore Related Videos
Related Concept Videos
01:29Inflammatory Bowel Disease IV: Pharmacological Management
79
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
79
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
219
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
219
01:21Inflammatory Bowel Disease V: Surgical Management
55
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
55
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
91
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
91
01:30Inflammatory Bowel Disease II: Crohn's Disease
122
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
122
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
97
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
97